A detailed history of Eagle Bay Advisors LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Eagle Bay Advisors LLC holds 5,042 shares of JNJ stock, worth $781,711. This represents 0.48% of its overall portfolio holdings.

Number of Shares
5,042
Previous 4,928 2.31%
Holding current value
$781,711
Previous $720,000 13.47%
% of portfolio
0.48%
Previous 0.44%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$145.48 - $167.38 $16,584 - $19,081
114 Added 2.31%
5,042 $817,000
Q2 2024

Jul 26, 2024

SELL
$144.38 - $157.78 $74,500 - $81,414
-516 Reduced 9.48%
4,928 $720,000
Q1 2024

May 08, 2024

SELL
$155.22 - $162.74 $18,936 - $19,854
-122 Reduced 2.19%
5,444 $861,000
Q4 2023

Feb 08, 2024

SELL
$145.6 - $158.88 $65,083 - $71,019
-447 Reduced 7.43%
5,566 $872,000
Q3 2023

Nov 13, 2023

BUY
$155.75 - $174.48 $272,874 - $305,688
1,752 Added 41.12%
6,013 $936,000
Q2 2023

Aug 10, 2023

SELL
$154.35 - $166.11 $9,878 - $10,631
-64 Reduced 1.48%
4,261 $705,000
Q1 2023

Apr 24, 2023

SELL
$151.05 - $180.26 $110,266 - $131,589
-730 Reduced 14.44%
4,325 $670,000
Q4 2022

Jan 26, 2023

SELL
$160.2 - $179.79 $24,030 - $26,968
-150 Reduced 2.88%
5,055 $0
Q3 2022

Nov 22, 2022

SELL
$161.33 - $179.52 $21,618 - $24,055
-134 Reduced 2.51%
5,205 $852,000
Q2 2022

Aug 19, 2022

BUY
$168.19 - $186.01 $77,703 - $85,936
462 Added 9.47%
5,339 $948 Million
Q1 2022

May 11, 2022

BUY
$158.14 - $179.59 $33,367 - $37,893
211 Added 4.52%
4,877 $864,000
Q4 2021

Jan 21, 2022

SELL
$155.93 - $173.01 $232,023 - $257,438
-1,488 Reduced 24.18%
4,666 $799,000
Q3 2021

Nov 12, 2021

BUY
$161.5 - $179.47 $243,542 - $270,640
1,508 Added 32.46%
6,154 $991,000
Q2 2021

Jul 30, 2021

BUY
$159.48 - $171.07 $740,944 - $794,791
4,646 New
4,646 $770,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Eagle Bay Advisors LLC Portfolio

Follow Eagle Bay Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Bay Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Bay Advisors LLC with notifications on news.